Viral evasion of intracellular DNA and RNA sensing

Nature Reviews Microbiology

Volumn 14, Issue 6, 2016, Pages 360-373

  Chan, Ying Kai ^a   Gack, Michaela U ^b  

^a HARVARD MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF CHICAGO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADAPTOR PROTEIN; CYCLIC AMP; CYCLIC GMP; GAMMA INTERFERON; GAMMA INTERFERON INDUCIBLE PROTEIN 16; NUCLEIC ACID; PATTERN RECOGNITION RECEPTOR; PROTEIN; UNCLASSIFIED DRUG; VIRUS DNA; VIRUS RNA; IFI16 PROTEIN, HUMAN; INFLAMMASOME; INTERFERON INDUCING AGENT; NUCLEAR PROTEIN; PHOSPHOPROTEIN; RETINOIC ACID INDUCIBLE PROTEIN I;

CARBOXY TERMINAL SEQUENCE; CELLULAR IMMUNITY; ENZYME ACTIVITY; HUMAN; IMMUNE EVASION; IMMUNOSURVEILLANCE; INNATE IMMUNITY; NONHUMAN; PRIORITY JOURNAL; PROTEIN CLEAVAGE; PROTEIN DEGRADATION; PROTEIN DEPHOSPHORYLATION; PROTEIN PROCESSING; REVIEW; RNA REPLICATION; VIRION; VIRUS GENOME; VIRUS IMMUNITY; VIRUS PATHOGENESIS; VIRUS REPLICATION; ANIMAL; CYTOPLASM; GENETICS; IMMUNOLOGY; METABOLISM; PATHOGENICITY; SIGNAL TRANSDUCTION; VIRUS;

ANIMALS; CYTOPLASM; DEAD BOX PROTEIN 58; DNA, VIRAL; HUMANS; IMMUNE EVASION; IMMUNITY, INNATE; INFLAMMASOMES; INTERFERON INDUCERS; NUCLEAR PROTEINS; PHOSPHOPROTEINS; PROTEIN PROCESSING, POST-TRANSLATIONAL; RECEPTORS, PATTERN RECOGNITION; RNA, VIRAL; SIGNAL TRANSDUCTION; VIRUSES;

EID: 84967215091     PISSN: 17401526     EISSN: 17401534     Source Type: Journal    
DOI: 10.1038/nrmicro.2016.45     Document Type: Review

References (164)

1. Takeuchi, O. & Akira, S. Pattern recognition receptors and inflammation. Cell 140, 805-820 (2010).
2. Dambuza, I. M. & Brown, G. D. C-type lectins in immunity: recent developments. Curr. Opin. Immunol. 32, 21-27 (2015).
3. Goubau, D., Deddouche, S. & Reis e Sousa, C. Cytosolic sensing of viruses. Immunity 38, 855-869 (2013).
4. Schneider, W. M., Chevillotte, M. D. & Rice, C. M. Interferon-stimulated genes: a complex web of host defenses. Annu. Rev. Immunol. 32, 513-545 (2014).
5. Yoneyama, M. et al. The RNA helicase RIG-I has an essential function in double-stranded RNA-induced innate antiviral responses. Nat. Immunol. 5, 730-737 (2004).
6. Andrejeva, J. et al. The V proteins of paramyxoviruses bind the IFN-inducible RNA helicase, MDA5, and inhibit its activation of the IFN-β promoter. Proc. Natl Acad. Sci. USA 101, 17264-17269 (2004).
7. Bruns, A. M. & Horvath, C. M. LGP2 synergy with MDA5 in RLR-mediated RNA recognition and antiviral signaling. Cytokine 74, 198-206 (2015).
8. Kato, H. et al. Differential roles of MDA5 and RIG-I helicases in the recognition of RNA viruses. Nature 441, 101-105 (2006).
9. Loo, Y. M. et al. Distinct RIG-I and MDA5 signaling by RNA viruses in innate immunity. J. Virol. 82, 335-345 (2008).
10. Schlee, M. Master sensors of pathogenic RNA-RIG-I like receptors. Immunobiology 218, 1322-1335 (2013).
11. Rasmussen, S. B. et al. Herpes simplex virus infection is sensed by both Toll-like receptors and retinoic acid-inducible gene-like receptors, which synergize to induce type I interferon production. J. Gen. Virol. 90, 74-78 (2009).
12. West, J. A. et al. An important role for mitochondrial antiviral signaling protein in the Kaposi's sarcoma-associated herpesvirus life cycle. J. Virol. 88, 5778-5787 (2014).
13. Chiang, J. J., Davis, M. E. & Gack, M. U. Regulation of RIG-I-like receptor signaling by host and viral proteins. Cytokine Growth Factor Rev. 25, 491-505 (2014).
14. Gack, M. U., Nistal-Villan, E., Inn, K. S., Garcia-Sastre, A. & Jung, J. U. Phosphorylation-mediated negative regulation of RIG-I antiviral activity. J. Virol. 84, 3220-3229 (2010).
15. Maharaj, N. P., Wies, E., Stoll, A. & Gack, M. U. Conventional protein kinase C-a(PKC-a) and PKC-p negatively regulate RIG-I antiviral signal transduction. J. Virol. 86, 1358-1371 (2012).
16. Wies, E. et al. Dephosphorylation of the RNA sensors RIG-I and MDA5 by the phosphatase PP1 is essential for innate immune signaling. Immunity 38, 437-449 (2013).
17. Sun, Z., Ren, H., Liu, Y, Teeling, J. L. & Gu, J. Phosphorylation of RIG-I by casein kinase II inhibits its antiviral response. J. Virol. 85, 1036-1047 (2011).
18. Takashima, K., Oshiumi, H., Takaki, H., Matsumoto, M. & Seya, T. RIOK3-mediated phosphorylation of MDA5 interferes with its assembly and attenuates the innate immune response. Cell Rep. 11, 192-200 (2015).
19. Kolakofsky, D., Kowalinski, E. & Cusack, S. A structure-based model of RIG-I activation. RNA 18, 2118-2127 (2012).
20. Kowalinski, E. et al. Structural basis for the activation of innate immune pattern-recognition receptor RIG-I by viral RNA. Cell 147, 423-435 (2011).
21. Kok, K. H. et al. The double-stranded RNA-binding protein PACT functions as a cellular activator of RIG-I to facilitate innate antiviral response. Cell Host Microbe 9, 299-309 (2011).
22. Gack, M. U. et al. TRIM25 RING-finger E3 ubiquitin ligase is essential for RIG-I-mediated antiviral activity. Nature 446, 916-920 (2007).
23. Oshiumi, H., Miyashita, M., Matsumoto, M. & Seya, T. A distinct role of Riplet-mediated K63-linked polyubiquitination of the RIG-I repressor domain in human antiviral innate immune responses. PLoS Pathog. 9, e1003533 (2013).
24. Horner, S. M., Liu, H. M., Park, H. S., Briley, J. & Gale, M. Mitochondrial-associated endoplasmic reticulum membranes (MAM) form innate immune synapses and are targeted by hepatitis C virus. Proc. Natl Acad. Sci. USA 108, 14590-14595 (2011).
25. Zeng, W et al. Reconstitution of the RIG-I pathway reveals a signaling role of unanchored polyubiquitin chains in innate immunity. Cell 141, 315-330 (2010).
26. Liu, H. M. et al. The mitochondrial targeting chaperone 14-3-3e regulates a RIG-I translocon that mediates membrane association and innate antiviral immunity. Cell Host Microbe 11, 528-537 (2012).
27. Wu, B. et al. Structural basis for dsRNA recognition, filament formation, and antiviral signal activation by MDA5. Cell 152, 276-289 (2013).
28. Dixit, E. et al. Peroxisomes are signaling platforms for antiviral innate immunity. Cell 141, 668-681 (2010).
29. Hou, F et al. MAVS forms functional prion-like aggregates to activate and propagate antiviral innate immune response. Cell 146, 448-461 (2011).
30. Sato, S. et al. The RNA sensor RIG-I dually functions as an innate sensor and direct antiviral factor for hepatitis B virus. Immunity 42, 123-132 (2015).
31. Weber, M. et al. Influenza virus adaptation PB2-627K modulates nucleocapsid inhibition by the pathogen sensor RIG-I. Cell Host Microbe 17, 309-319 (2015).
32. Yao, H. et al. ATP-dependent effector-like functions of RIG-I-like receptors. Mol. Cell 58, 541-548 (2015).
33. Dempsey, A. & Bowie, A. G. Innate immune recognition of DNA: a recent history. Virology 479-480, 146-152 (2015).
34. Zhong, B. et al. The adaptor protein MITA links virus-sensing receptors to IRF3 transcription factor activation. Immunity 29, 538-550 (2008).
35. Ishikawa, H., Ma, Z. & Barber, G. N. STING regulates intracellular DNA-mediated, type I interferon-dependent innate immunity. Nature 461, 788-792 (2009).
36. Sun, W. et al. ERIS, an endoplasmic reticulum IFN stimulator, activates innate immune signaling through dimerization. Proc. Natl Acad. Sci. USA 106, 8653-8658 (2009).
37. Sun, L., Wu, J., Du, F., Chen, X. & Chen, Z. J. Cyclic GMP-AMP synthase is a cytosolic DNA sensor that activates the type I interferon pathway. Science 339, 786-791 (2013).
38. Gao, D. et al. Cyclic GMP-AMP synthase is an innate immune sensor of HIV and other retroviruses. Science 341, 903-906 (2013).
39. Li, X. D. et al. Pivotal roles of cGAS-cGAMP signaling in antiviral defense and immune adjuvant effects. Science 341, 1390-1394 (2013).
40. Schoggins, J. W. et al. Pan-viral specificity of IFN-induced genes reveals new roles for cGAS in innate immunity. Nature 505, 691-695 (2014).
41. Wu, J. et al. Cyclic GMP-AMP is an endogenous second messenger in innate immune signaling by cytosolic DNA. Science 339, 826-830 (2013).
42. Gao, P. et al. Cyclic [G(2′, 5′)pA(3′, 5′)p] is the metazoan second messenger produced by DNA-activated cyclic GMP-AMP synthase. Cell 153, 1094-1107 (2013).
43. Ablasser, A. et al. cGAS produces a 2′-5′-linked cyclic dinucleotide second messenger that activates STING. Nature 498, 380-384 (2013).
44. Ablasser, A. et al. Cell intrinsic immunity spreads to bystander cells via the intercellular transfer of cGAMP. Nature 503, 530-534 (2013).
45. Tsuchida, T. et al. The ubiquitin ligase TRIM56 regulates innate immune responses to intracellular double-stranded DNA. Immunity 33, 765-776 (2010).
46. Zhang, J., Hu, M. M., Wang, Y. Y. & Shu, H. B. TRIM32 protein modulates type I interferon induction and cellular antiviral response by targeting MITA/STING protein for K63-linked ubiquitination. J. Biol. Chem. 287, 28646-28655 (2012).
47. Liu, S. et al. Phosphorylation of innate immune adaptor proteins MAVS, STING, and TRIF induces IRF3 activation. Science 347, aaa2630 (2015).
48. Tanaka, Y. & Chen, Z. J. STING specifies IRF3 phosphorylation by TBK1 in the cytosolic DNA signaling pathway. Sci. Signal. 5, ra20 (2012).
49. Unterholzner, L. et al. IFI16 is an innate immune sensor for intracellular DNA. Nat. Immunol. 11, 997-1004 (2010).
50. Jin, T. et al. Structures of the HIN domain: DNA complexes reveal ligand binding and activation mechanisms of the AIM2 inflammasome and IFI16 receptor. Immunity 36, 561-571 (2012).
51. Bowie, A. G. & Unterholzner, L. Viral evasion and subversion of pattern-recognition receptor signalling. Nat. Rev. Immunol. 8, 911-922 (2008).
52. Taylor, K. E. & Mossman, K. L. Recent advances in understanding viral evasion of type I interferon. Immunology 138, 190-197 (2013).
53. Uchida, L. et al. The dengue virus conceals double-stranded RNA in the intracellular membrane to escape from an interferon response. Sci. Rep. 4, 7395 (2014).
54. Cardenas, W. B. et al. Ebola virus VP35 protein binds double-stranded RNA and inhibits a/p-interferon production induced by RIG-I signaling. J. Virol. 80, 5168-5178 (2006).
55. Ramanan, P. et al. Structural basis for Marburg virus VP35-mediated immune evasion mechanisms. Proc. Natl Acad. Sci. USA 109, 20661-20666 (2012).
56. Hatada, E. & Fukuda, R. Binding of influenza A virus NS1 protein to dsRNA in vitro. J. Gen. Virol. 73, 3325-3329 (1992).
57. Qian, X. Y, Chien, C. Y, Lu, Y, Montelione, G. T & Krug, R. M. An amino-terminal polypeptide fragment of the influenza virus NS1 protein possesses specific RNA-binding activity and largely helical backbone structure. RNA 1, 948-956 (1995).
58. Donelan, N. R., Basler, C. F. & Garcia-Sastre, A. A recombinant influenza A virus expressing an RNA-binding-defective NS1 protein induces high levels of (interferon and is attenuated in mice. J. Virol. 77, 13257-13266 (2003).
59. Valentine, R. & Smith, G. L. Inhibition of the RNA polymerase III-mediated dsDNA-sensing pathway of innate immunity by vaccinia virus protein E3. J. Gen. Virol. 91, 2221-2229 (2010).
60. Bitko, V, Musiyenko, A., Bayfield, M. A., Maraia, R. J. & Barik, S. Cellular La protein shields nonsegmented negative-strand RNA viral leader RNA from RIG-I and enhances virus growth by diverse mechanisms. J. Virol. 82, 7977-7987 (2008).
61. Boonyaratanakornkit, J. et al. The C proteins of human parainfluenza virus type 1 limit double-stranded RNA accumulation that would otherwise trigger activation of MDA5 and protein kinase R. J. Virol. 85, 1495-1506 (2011).
62. Habjan, M. et al. Processing of genome 5'termini as a strategy of negative-strand RNA viruses to avoid RIG-I-dependent interferon induction. PLoS ONE 3, e2032 (2008).
63. Wang, H., Vaheri, A., Weber, F & Plyusnin, A. Old World hantaviruses do not produce detectable amounts of dsRNA in infected cells and the 5' termini of their genomic RNAs are monophosphorylated. J. Gen. Virol. 92, 1199-1204 (2011).
64. Marq, J. B., Kolakofsky, D. & Garcin, D. Unpaired 5'-ppp-nucleotides, as found in arenavirus double-stranded RNA panhandles, are not recognized by RIG-I. J. Biol. Chem. 285, 18208-18216 (2010).
65. Marq, J. B., Hausmann, S., Veillard, N., Kolakofsky, D. & Garcin, D. Short double-stranded RNAs with an overhanging 5'-ppp-nucleotide, as found in arenavirus genomes, act as RIG-I decoys. J. Biol. Chem. 286, 6108-6116 (2011).
66. Hastie, K. M., Kimberlin, C. R., Zandonatti, M. A., MacRae, I. J. & Saphire, E. O. Structure of the Lassa virus nucleoprotein reveals a dsRNA-specific 3'-to-5' exonuclease activity essential for immune suppression. Proc. Natl Acad. Sci. USA 108, 2396-2401 (2011).
67. Reynard, S., Russier, M., Fizet, A., Carnec, X. & Baize, S. Exonuclease domain of the Lassa virus nucleoprotein is critical to avoid RIG-I signaling and to inhibit the innate immune response. J. Virol. 88, 13923-13927 (2014).
68. Gack, M. U. et al. Influenza A virus NS1 targets the ubiquitin ligase TRIM25 to evade recognition by the host viral RNA sensor RIG-I. Cell Host Microbe 5, 439-449 (2009).
69. Rajsbaum, R. et al. Species-specific inhibition of RIG-I ubiquitination and IFN induction by the influenza A virus NS1 protein. PLoS Pathog. 8, e1003059 (2012).
70. Inn, K. S. et al. Inhibition of RIG-I-mediated signaling by Kaposi's sarcoma-associated herpesvirus-encoded deubiquitinase ORF64. J. Virol. 85, 10899-10904 (2011).
71. Clementz, M. A. et al. Deubiquitinating and interferon antagonism activities of coronavirus papain-like proteases. J. Virol. 84, 4619-4629 (2010).
72. Wang, D. et al. The leader proteinase of foot-and-mouth disease virus negatively regulates the type I interferon pathway by acting as a viral deubiquitinase. J. Virol. 85, 3758-3766 (2011).
73. van Kasteren, P. B. et al. Deubiquitinase function of arterivirus papain-like protease 2 suppresses the innate immune response in infected host cells. Proc. Natl Acad. Sci. USA 110, E838-E847 (2013).
74. Xu, C. et al. Downregulation of microRNA miR-526a by enterovirus inhibits RIG-I-dependent innate immune response. J. Virol. 88, 11356-11368 (2014).
75. Manokaran, G. et al. Dengue subgenomic RNA binds TRIM25 to inhibit interferon expression for epidemiological fitness. Science 350, 217-221 (2015).
76. Pauli, E. K. et al. The ubiquitin-specific protease USP15 promotes RIG-I-mediated antiviral signaling by deubiquitylating TRIM25. Sci. Signal. 7, ra3 (2014).
77. Davis, M. E. et al. Antagonism of the phosphatase PP1 by the measles virus V protein is required for innate immune escape of MDA5. Cell Host Microbe 16, 19-30 (2014).
78. Mesman, A. W. et al. Measles virus suppresses RIG-I-like receptor activation in dendritic cells via DC-SIGN-mediated inhibition of PP1 phosphatases. Cell Host Microbe 16, 31-42 (2014).
79. Barral, P. M., Sarkar, D., Fisher, P. B. & Racaniello, V. R. RIG-I is cleaved during picornavirus infection. Virology 391, 171-176 (2009).
80. pro targets MDA5 and MAVS in infected cells. J. Virol. 88, 3369-3378 (2014).
81. Mukherjee, A. et al. The coxsackievirus B 3C protease cleaves MAVS and TRIF to attenuate host type I interferon and apoptotic signaling. PLoS Pathog. 7, e1001311 (2011).
82. Li, X. D., Sun, L., Seth, R. B., Pineda, G. & Chen, Z. J. Hepatitis C virus protease NS3/4A cleaves mitochondrial antiviral signaling protein off the mitochondria to evade innate immunity. Proc. Natl Acad. Sci. USA 102, 17717-17722 (2005).
83. Yang, Y. et al. Disruption of innate immunity due to mitochondrial targeting of a picornaviral protease precursor. Proc. Natl Acad. Sci. USA 104, 7253-7258 (2007).
84. Chen, Z. et al. GB virus B disrupts RIG-I signaling by NS3/4A-mediated cleavage of the adaptor protein MAVS. J. Virol. 81, 964-976 (2007).
85. Drahos, J. & Racaniello, V. R. Cleavage of IPS-1 in cells infected with human rhinovirus. J. Virol. 83, 11581-11587 (2009).
86. Yoshizumi, T. et al. Influenza A virus protein PB1-F2 translocates into mitochondria via Tom40 channels and impairs innate immunity. Nat. Commun. 5, 4713 (2014).
87. Varga, Z. T., Grant, A., Manicassamy, B. & Palese, P. Influenza virus protein PB1-F2 inhibits the induction of type I interferon by binding to MAVS and decreasing mitochondrial membrane potential. J. Virol. 86, 8359-8366 (2012).
88. Wei, C. et al. The hepatitis B virus X protein disrupts innate immunity by downregulating mitochondrial antiviral signaling protein. J. Immunol. 185, 1158-1168 (2010).
89. Barral, P. M. et al. MDA-5 is cleaved in poliovirus-infected cells. J. Virol. 81, 3677-3684 (2007).
90. Xia, M. et al. Mitophagy enhances oncolytic measles virus replication by mitigating DDX58/RIG-I-like receptor signaling. J. Virol. 88, 5152-5164 (2014).
91. Shi, C. S. et al. SARS-coronavirus open reading frame-9b suppresses innate immunity by targeting mitochondria and the MAVS/TRAF3/TRAF6 signalosome. J. Immunol. 193, 3080-3089 (2014).
92. Goswami, R. et al. Viral degradasome hijacks mitochondria to suppress innate immunity. Cell Res. 23, 1025-1042 (2013).
93. You, J. et al. Flavivirus infection impairs peroxisome biogenesis and early antiviral signaling. J. Virol. 89, 12349-12361 (2015).
94. Rodriguez, K. R. & Horvath, C. M. Amino acid requirements for MDA5 and LGP2 recognition by paramyxovirus V proteins: a single arginine distinguishes MDA5 from RIG-I. J. Virol. 87, 2974-2978 (2013).
95. Motz, C. et al. Paramyxovirus V proteins disrupt the fold of the RNA sensor MDA5 to inhibit antiviral signaling. Science 339, 690-693 (2013).
96. Childs, K. S., Andrejeva, J., Randall, R. E. & Goodbourn, S. Mechanism of MDA5 inhibition by paramyxovirus V proteins. J. Virol. 83, 1465-1473 (2009).
97. Luthra, P. et al. Mutual antagonism between the Ebola virus VP35 protein and the RIG-I activator PACT determines infection outcome. Cell Host Microbe 14, 74-84 (2013).
98. Tawaratsumida, K. et al. Quantitative proteomic analysis of the influenza A virus nonstructural proteins NS1 and NS2 during natural cell infection identifies PACT as an NS1 target protein and antiviral host factor. J. Virol. 88, 9038-9048 (2014).
99. Siu, K. L. et al. Middle east respiratory syndrome coronavirus 4a protein is a double-stranded RNA-binding protein that suppresses PACT-induced activation of RIG-I and MDA5 in the innate antiviral response. J. Virol. 88, 4866-4876 (2014).
100. Siu, K. L. et al. Severe acute respiratory syndrome coronavirus M protein inhibits type I interferon production by impeding the formation of TRAF3-TANK-TBK1/IKKϵ complex. J. Biol. Chem. 284, 16202-16209 (2009).
101. Fan, L., Briese, T. & Lipkin, W. I. Z proteins of New World arenaviruses bind RIG-I and interfere with type I interferon induction. J. Virol. 84, 1785-1791 (2010).
102. Xing, J., Ly, H. & Liang, Y. The Z proteins of pathogenic but not nonpathogenic arenaviruses inhibit RIG-I-like receptor-dependent interferon production. J. Virol. 89, 2944-2955 (2015).
103. Bao, X. et al. Human metapneumovirus glycoprotein G inhibits innate immune responses. PLoS Pathog. 4, e1000077 (2008).
104. Chan, Y. K. & Gack, M. U. A phosphomimetic-based mechanism of dengue virus to antagonize innate immunity. Nat. Immunol. 17, 523-530 (2016).
105. Lifland, A. W. et al. Human respiratory syncytial virus nucleoprotein and inclusion bodies antagonize the innate immune response mediated by MDA5 and MAVS. J. Virol. 86, 8245-8258 (2012).
106. Santiago, F. W. et al. Hijacking of RIG-I signaling proteins into virus-induced cytoplasmic structures correlates with the inhibition of type I interferon responses. J. Virol. 88, 4572-4585 (2014).
107. Ng, C. S. et al. Encephalomyocarditis virus disrupts stress granules, the critical platform for triggering antiviral innate immune responses. J. Virol. 87, 9511-9522 (2013).
108. White, J. P., Cardenas, A. M., Marissen, W. E. & Lloyd, R. E. Inhibition of cytoplasmic mRNA stress granule formation by a viral proteinase. Cell Host Microbe 2, 295-305 (2007).
109. Yan, N., Regalado-Magdos, A. D., Stiggelbout, B., Lee-Kirsch, M. A. & Lieberman, J. The cytosolic exonuclease TREX1 inhibits the innate immune response to human immunodeficiency virus type 1. Nat. Immunol. 11, 1005-1013 (2010).
110. Rasaiyaah, J. et al. HIV-1 evades innate immune recognition through specific cofactor recruitment. Nature 503, 402-405 (2013).
111. Lahaye, X. et al. The capsids of HIV-1 and HIV-2 determine immune detection of the viral cDNA by the innate sensor cGAS in dendritic cells. Immunity 39, 1132-1142 (2013).
112. Liu, Y. et al. Hepatitis B virus polymerase disrupts K63-linked ubiquitination of STING to block innate cytosolic DNA-sensing pathways. J. Virol. 89, 2287-2300 (2015).
113. Chen, X. et al. SARS coronavirus papain-like protease inhibits the type I interferon signaling pathway through interaction with the STING-TRAF3-TBK1 complex. Protein Cell 5, 369-381 (2014).
114. Sun, L. et al. Coronavirus papain-like proteases negatively regulate antiviral innate immune response through disruption of STING-mediated signaling. PLoS ONE 7, e30802 (2012).
115. Xing, Y. et al. The papain-like protease of porcine epidemic diarrhea virus negatively regulates type I interferon pathway by acting as a viral deubiquitinase. J. Gen. Virol. 94, 1554-1567 (2013).
116. Nitta, S. et al. Hepatitis C virus NS4B protein targets STING and abrogates RIG-I-mediated type I interferon-dependent innate immunity. Hepatology 57, 46-58 (2013).
117. Ding, Q. et al. Hepatitis C virus NS4B blocks the interaction of STING and TBK1 to evade host innate immunity. J. Hepatol 59, 52-58 (2013).
118. Lau, L., Gray, E. E., Brunette, R. L. & Stetson, D. B. DNA tumor virus oncogenes antagonize the cGAS-STING DNA sensing pathway. Science 350, 568-571 (2015).
119. Ma, Z. et al. Modulation of the cGAS-STING DNA sensing pathway by gammaherpesviruses. Proc. Natl Acad. Sci. USA 112, E4306-E4315 (2015).
120. Sun, C. et al. Evasion of innate cytosolic DNA sensing by a gammaherpesvirus facilitates establishment of latent infection. J. Immunol. 194, 1819-1831 (2015).
121. Orzalli, M. H., DeLuca, N. A. & Knipe, D. M. Nuclear IFI16 induction of IRF-3 signaling during herpesviral infection and degradation of IFI16 by the viral ICP0 protein. Proc. Natl Acad. Sci. USA 109, E3008-E3017 (2012).
122. Cuchet-Lourenco, D., Anderson, G., Sloan, E., Orr, A. & Everett, R. D. The viral ubiquitin ligase ICP0 is neither sufficient nor necessary for degradation of the cellular DNA sensor IFI16 during herpes simplex virus 1 infection. J. Virol. 87, 13422-13432 (2013).
123. Diner, B. A., Lum, K. K., Javitt, A. & Cristea, I. M. Interactions of the antiviral factor interferon γ-inducible protein 16 (IFI16) mediate immune signaling and herpes simplex virus-1 immunosuppression. Mol. Cell Proteomics 14, 2341-2356 (2015).
124. Aguirre, S. et al. DENV inhibits type I IFN production in infected cells by cleaving human STING. PLoS Pathog. 8, e1002934 (2012).
125. Yu, C. Y. et al. Dengue virus targets the adaptor protein MITA to subvert host innate immunity. PLoS Pathog. 8, e1002780 (2012).
126. Wu, J. J. et al. Inhibition of cGAS DNA sensing by a herpesvirus virion protein. Cell Host Microbe 18, 333-344 (2015).
127. Li, T., Chen, J. & Cristea, I. M. Human cytomegalovirus tegument protein pUL83 inhibits IFI16-mediated DNA sensing for immune evasion. Cell Host Microbe 14, 591-599 (2013).
128. Varnum, S. M. et al. Identification of proteins in human cytomegalovirus (HCMV) particles: the HCMV proteome. J. Virol. 78, 10960-10966 (2004).
129. Dell'Oste, V. et al. Innate nuclear sensor IFI16 translocates into the cytoplasm during the early stage of in vitro human cytomegalovirus infection and is entrapped in the egressing virions during the late stage. J. Virol. 88, 6970-6982 (2014).
130. Deretic, V., Saitoh, T. & Akira, S. Autophagy in infection, inflammation and immunity. Nat. Rev. Immunol. 13, 722-737 (2013).
131. Kato, H. & Fujita, T. RIG-I-like receptors and autoimmune diseases. Curr. Opin. Immunol. 37, 40-45 (2015).
132. Dalet, A., Gatti, E. & Pierre, P. Integration of PKR-dependent translation inhibition with innate immunity is required for a coordinated anti-viral response. FEBS Lett. 589, 1539-1545 (2015).
133. Lloyd, R. E. Regulation of stress granules and P-bodies during RNA virus infection. Wiley Interdiscip Rev. RNA 4, 317-331 (2013).
134. Hornung, V., Hartmann, R., Ablasser, A. & Hopfner, K. P. OAS proteins and cGAS: unifying concepts in sensing and responding to cytosolic nucleic acids. Nat. Rev. Immunol. 14, 521-528 (2014).
135. Malathi, K., Dong, B., Gale, M. & Silverman, R. H. Small self-RNA generated by RNase L amplifies antiviral innate immunity. Nature 448, 816-819 (2007).
136. Oshiumi, H. et al. DDX60 is involved in RIG-I-dependent and independent antiviral responses, and its function is attenuated by virus-induced EGFR activation. Cell Rep. 11, 1193-1207 (2015).
137. Hornung, V. et al. AIM2 recognizes cytosolic dsDNA and forms a caspase-1-activating inflammasome with ASC. Nature 458, 514-518 (2009).
138. Rathinam, V. A. et al. The AIM2 inflammasome is essential for host defense against cytosolic bacteria and DNA viruses. Nat. Immunol. 11, 395-402 (2010).
139. Wen, H., Miao, E. A. & Ting, J. P. Mechanisms of NOD-like receptor-associated inflammasome activation. Immunity 39, 432-441 (2013).
140. Kanneganti, T. D. Central roles of NLRs and inflammasomes in viral infection. Nat. Rev. Immunol. 10, 688-698 (2010).
141. Sabbah, A. et al. Activation of innate immune antiviral responses by NOD2. Nat. Immunol. 10, 1073-1080 (2009).
142. Allen, I. C. et al. The NLRP3 inflammasome mediates in vivo innate immunity to influenza A virus through recognition of viral RNA. Immunity 30, 556-565 (2009).
143. Ichinohe, T., Lee, H. K., Ogura, Y., Flavell, R. & Iwasaki, A. Inflammasome recognition of influenza virus is essential for adaptive immune responses. J. Exp. Med. 206, 79-87 (2009).
144. Poeck, H. et al. Recognition of RNA virus by RIG-I results in activation of CARD9 and inflammasome signaling for interleukin 1β production. Nat. Immunol. 11, 63-69 (2010).
145. Hornung, V. et al. 5′-triphosphate RNA is the ligand for RIG-I. Science 314, 994-997 (2006).
146. Pichlmair, A. et al. RIG-I-mediated antiviral responses to single-stranded RNA bearing 5′-phosphates. Science 314, 997-1001 (2006).
147. Goubau, D. et al. Antiviral immunity via RIG-I-mediated recognition of RNA bearing 5′-diphosphates. Nature 514, 372-375 (2014).
148. Saito, T., Owen, D. M., Jiang, F., Marcotrigiano, J. & Gale, M. Innate immunity induced by composition-dependent RIG-I recognition of hepatitis C virus RNA. Nature 454, 523-527 (2008).
149. Uzri, D. & Gehrke, L. Nucleotide sequences and modifications that determine RIG-I/RNA binding and signaling activities. J. Virol. 83, 4174-4184 (2009).
150. Baum, A., Sachidanandam, R. & Garcia-Sastre, A. Preference of RIG-I for short viral RNA molecules in infected cells revealed by next-generation sequencing. Proc. Natl Acad. Sci. USA 107, 16303-16308 (2010).
151. Rehwinkel, J. et al. RIG-I detects viral genomic RNA during negative-strand RNA virus infection. Cell 140, 397-408 (2010).
152. Pichlmair, A. et al. Activation of MDA5 requires higher-order RNA structures generated during virus infection. J. Virol. 83, 10761-10769 (2009).
153. Zust, R. et al. Ribose 2′-O-methylation provides a molecular signature for the distinction of self and non-self mRNA dependent on the RNA sensor MDA5. Nat. Immunol. 12, 137-143 (2011).
154. Herzner, A. M. et al. Sequence-specific activation of the DNA sensor cGAS by Y-form DNA structures as found in primary HIV-1 cDNA. Nat. Immunol. 16, 1025-1033 (2015).
155. Orzalli, M. H. & Knipe, D. M. Cellular sensing of viral DNA and viral evasion mechanisms. Annu. Rev. Microbiol. 68, 477-492 (2014).
156. Orzalli, M. H. et al. cGAS-mediated stabilization of IFI16 promotes innate signaling during herpes simplex virus infection. Proc. Natl Acad. Sci. USA 112, E1773-E1781 (2015).
157. Muruve, D. A. et al. The inflammasome recognizes cytosolic microbial and host DNA and triggers an innate immune response. Nature 452, 103-107 (2008).
158. Kanneganti, T. D. et al. Critical role for Cryopyrin/Nalp3 in activation of caspase-1 in response to viral infection and double-stranded RNA. J. Biol. Chem. 281, 36560-36568 (2006).
159. Stasakova, J. et al. Influenza A mutant viruses with altered NS1 protein function provoke caspase-1 activation in primary human macrophages, resulting in fast apoptosis and release of high levels of interleukins 1β and 18. J. Gen. Virol. 86, 185-195 (2005).
160. Komune, N., Ichinohe, T., Ito, M. & Yanagi, Y. Measles virus V protein inhibits NLRP3 inflammasome-mediated interleukin-1β secretion. J. Virol. 85, 13019-13026 (2011).
161. Johnston, J. B. et al. A poxvirus-encoded pyrin domain protein interacts with ASC-1 to inhibit host inflammatory and apoptotic responses to infection. Immunity 23, 587-598 (2005).
162. Dorfleutner, A. et al. A Shope fibroma virus PYRIN-only protein modulates the host immune response. Virus Genes 35, 685-694 (2007).
163. Gerlic, M. et al. Vaccinia virus F1L protein promotes virulence by inhibiting inflammasome activation. Proc. Natl Acad. Sci. USA 110, 7808-7813 (2013).
164. Gregory, S. M. et al. Discovery of a viral NLR homolog that inhibits the inflammasome. Science 331, 330-334 (2011).